Communiqué de presse
RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia
Clinical Trial Application approved in Russia for the Phase 2/3 study with opaganib in severe COVID-19 patients following recent approval […]
Vous n'êtes pas encore inscrit ?
InscriptionClinical Trial Application approved in Russia for the Phase 2/3 study with opaganib in severe COVID-19 patients following recent approval […]
HalioDx renforce son équipe de direction HalioDx SAS, la société de diagnostic en immuno-oncologie, a annoncé aujourd’hui un changement dans […]
Fait très rare, le site de production de tests sérologiques de Bio-Rad, spécialisé dans les maladies infectieuses, s’est ouvert […]
14 July 2020 A study undertaken by Eurofins scientists has resulted in a robust method to analyse SARS-CoV-2 in wastewater […]
Anticipated large, global Phase 2b/3 safety and efficacy study may begin as early as July 2020 NEW […]